Research


June 5, 2025

Arkansas’ Leading Cancer Researchers Gather at Winthrop P. Rockefeller Cancer Institute Retreat

Marty Trieschmann

Arkansas’ Leading Cancer Researchers Gather at Winthrop P. Rockefeller Cancer Institute’s Retreat

In a strong showing as the state’s leader in cancer research, the Winthrop P. Rockefeller Cancer Institute hosted its annual research retreat May 7 for scientists across the University of Arkansas for Medical Sciences (UAMS). Held at the Robinson Center Grand Ballroom in downtown Little Rock, the daylong event served as an opportunity for researchers…


April 22, 2025

UAMS Winthrop P. Rockefeller Cancer Institute Scientists Uncover New Opportunities for Targeted Cancer Therapies

Marty Trieschmann

Tudor Moldoveanu, Ph.D.

Molecular Cell publishes UAMS comprehensive structural biology study of MCL-1:BAK complex found in most cancers A research team led by UAMS Winthrop P. Rockefeller Cancer Institute scientist, Tudor Moldoveanu, Ph.D., has uncovered novel insights into one of the body’s most fundamental processes impacting the development of cancer. Known as apoptosis, the research on the process…


March 31, 2025

NIH Awards UAMS Nearly $3 Million to Study DNA Structures that Could Impact Cancer Treatment

David Robinson

Kevin Raney, Ph.D. (center), is leading exciting new research of unique DNA structures called quadruplexes with his team (l-r): Yu Chen, research assistant, Jun Gao, Ph.D., instructor Kirk West, Ph.D., assistant professor, Farhana Nasrin, Ph.D., assistant staff scientist, and John Marecki, Ph.D., instructor.

LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researcher Kevin Raney, Ph.D., has been awarded a five-year, $2.99 million grant from the National Institutes of Health (NIH) to study unusual DNA structures called quadruplexes, which may act like natural drugs by binding to key proteins involved in disease. The grant from the NIH…


March 6, 2025

UAMS Winthrop P. Rockefeller Cancer Institute Scientist Awarded $1.9 Million to Study Air Pollution, Breast Cancer

Marty Trieschmann

Ping-Ching Hsu, Ph.D.

A researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has received a $1.9 million grant from the National Institute of Environmental Health Sciences (NIEHS) to study the role of environmental exposures in the development of early onset breast cancer in Arkansas women. Ping-Ching Hsu, Ph.D., an…


October 15, 2024

UAMS Establishes Proteomics Center of Excellence in Little Rock with Thermo Fisher Scientific

Marty Trieschmann

UAMS Establishes Proteomics Center of Excellence in Little Rock with Thermo Fisher Scientific

The University of Arkansas for Medical Sciences (UAMS) announced the launch of the Thermo Fisher Scientific Center of Excellence for Proteomics at UAMS — the first and only academic-industry partnership of its kind in the United States. The world leader in serving science, Thermo Fisher Scientific, entered into a formal agreement with the IDeA National…


October 14, 2024

Symposium Showcases Promising Research Aimed at Reducing Cancer Therapy Side Effects

Marty Trieschmann

UAMS Cancer Researcher Amanda Stolarz. Ph.D.,

What is worse? Cancer or cancer treatment? Ask any patient treated with chemotherapy, and the answer may be the treatment. Common side effects of chemotherapy include pain, fatigue, hair loss, mouth sores, bowel issues as well as nerve, muscle, cell and organ damage. And that’s just chemotherapy. Conventional X-ray radiation, a treatment needed by half…


October 8, 2024

Marius Nagalo, Ph.D., First at UAMS to Receive NIH New Innovator Award

Marty Trieschmann

Marius Nagalo, Ph.D., (left) is the first UAMS researcher to receive the prestigious New Innovator Award from the National Institutes of Health.

LITTLE ROCK — A researcher at the Winthrop P Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), Marius Nagalo, Ph.D., has received the prestigious New Innovator Award from the National Institutes of Health (NIH).


July 25, 2024

UAMS’ Michael Birrer, M.D., Ph.D., Publishes Study Results in JAMA Oncology on Treatment for Incurable Cervical Cancer

Marty Trieschmann

UAMS’ Michael Birrer, M.D., Ph.D., Publishes Study Results in JAMA Oncology on Treatment for Incurable Cervical Cancer

The results of an international clinical trial led by Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), on the use of a novel bispecific antibody for women with recurrent or metastatic cervical cancer were published today in JAMA Oncology. Cervical cancer is…


June 27, 2024

UAMS Winthrop P. Rockefeller Cancer Institute Awarded Five New Grants from National Cancer Institute

Marty Trieschmann

UAMS Winthrop P. Rockefeller Cancer Institute Awarded Five New Grants from National Cancer Institute

Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) have been awarded five new grants from the National Cancer Institute (NCI) in 2024, totaling $4.6 million. New grants include: $3.3 million NCI grant to create a Melanoma Resistance Evolution Atlas, Principal Investigator: Alan Tackett, Ph.D., Winthrop P….


May 31, 2024

Cancer Institute Research Retreat Focuses on Prevention, Early Detection

Marty Trieschmann

UAMS cancer researchers talk about a study displaying on a poster in front of them

The third UAMS Winthrop P. Rockefeller Cancer Institute Cancer Research Retreat brought together more than 250 UAMS cancer researchers and faculty to share ongoing research on the prevention and early detection of cancer in Arkansas. An alarming statistic prompted the retreat’s prevention and early detection focus in the hopes that collaboration and sharing innovative strategies…



Previous page Next page